학술논문

Sequencing of Ipilimumab Plus Nivolumab and Encorafenib Plus Binimetinib for Untreated BRAF-Mutated Metastatic Melanoma (SECOMBIT): A Randomized, Three-Arm, Open-Label Phase II Trial
Document Type
Artikel
Source
Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 41(2):212-221
Subject
Medicin och hälsovetenskap
Language
English
English
ISSN
1527-7755